LumiraDx to sell point of care technology platform to Roche for $295M
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million,…
Bringing News as it Unfolds
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million,…